Agfa shows some losses in second quarter

Agfa-Gevaert has released its second quarter 2005 results with sales of $1.04 billion, a decrease of 15.6 percent compared to the 2004 second quarter sales of $1.23 billion.

The company's gross profit fell by 23.7 percent to $388.55 million compared to the same period in 2004. Year-on-year sales dropped 15.6 percent to $1.04 billion, affected by increased raw material costs and higher than expected price erosion, especially in HealthCare.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.